谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

MVA-5T4 immunotherapy (TroVax) and low-dose cyclophosphamide for advanced colorectal cancer (TaCTiCC): an open-label, randomized phase 1/2 clinical trial

Martin John Scurr,Thomas Pembroke,Anja Bloom,David Roberts,Amanda Thomson,Kathryn Smart,Hayley Bridgeman, Richard Admas,Alison Brewster, Robert Jones,Sarah Gwynne,Daniel Blount,Richard Harrop,Melissa Wright,Robert Kerrin Hills,Awen Myfanwy Gallimore,Andrew James Godkin

JAMA Oncology（2017）

引用 23|浏览32
暂无评分
关键词
advanced colorectal cancer,colorectal cancer,trovax,immunotherapy,low-dose,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要